About SpectraWAVE
SpectraWAVE is a Healthcare company based in Waltham (United States) founded in 2012 by Gregg Stone, Guillermo Tearney, and James Muller, and was acquired by Philips in December 2025. Photonic imaging diagnostics for cardiovascular disease treatment are provided. SpectraWAVE has raised $79.88 million across 3 funding rounds from investors including Nova Ventures Group, Philips and Johnson & Johnson Innovation – JJDC. The company has 36 employees. Its chief executive, as recorded, is Eman Namati. SpectraWAVE offers products and services including HyperVue Imaging System and Starlight Imaging Catheter. Its focus areas include Life Sciences, Imaging Diagnostics, OCT and Life Sciences Platforms and Tools. Its legal entity is SPECTRAWAVE, INC. Its competitors include NinePoint Medical and Ionpath; 2 of its 2 listed competitors have raised funding.
Company details
SpectraWAVE was founded in 2012 and is headquartered in Waltham, United States. Optical diagnostic and therapeutic devices are developed for the diagnosis and treatment of cardiovascular disease within the medical devices sector. Photonic imaging technology is employed to enable precise cardiovascular assessments. Operations center on advancing non-invasive solutions for clinical applications in cardiology.
- Headquarters Waltham, United States
- Employees 36
- Founders Gregg Stone, Guillermo Tearney, James Muller
- Stage Acquired
- SectorsHealthcare
- Website spectrawave.com
- Social LinkedIn X
- Acquired by Philips (Dec 2025)
- Legal Name Spectrawave, Inc.
- Total Equity Funding$79.88M (USD)
in 3 rounds
- Latest Funding Round$50.29M (USD), Series B
Sep 2024
- InvestorsNova Ventures Group
& 8 more
- Employee Count36
- Acquired byPhilips
(Dec 2025)
Products & Services of SpectraWAVE
SpectraWAVE offers a comprehensive portfolio of products and services, including HyperVue Imaging System and Starlight Imaging Catheter.
Offers high-resolution intravascular imaging for coronary artery analysis.
Enables imaging in vessels for interventional procedures and plaque assessment.
Funding Insights of SpectraWAVE
SpectraWAVE has successfully raised a total of $79.88M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $50.29 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $79.88M
- Total Rounds 3
- Last Round Series B — $50.29M
- First Round $16.4M
(May 2019)
- Investors Count 8
All 3 funding rounds of SpectraWAVE with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $50.29M | Series B | – | Johnson & Johnson Innovation – JJDC | |
| Feb 2021 | $13.2M | Series A | – | Deerfield | – |
| May 2019 | $16.4M | Series A | – | – | – |
9 investors in total: 9 institutional.
Investors in SpectraWAVE
SpectraWAVE has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Nova Ventures Group, Philips and Johnson & Johnson Innovation – JJDC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm backed by Johnson & Johnson | jnjinnovation.com/jjdc | Cambridge, United States | ||
Venture capital investments are provided to Texas-based startups. | 2005 | s3vc.com | Austin, United States | |
Lumira Ventures is engaged in life sciences venture capital investment. | lumiraventures.com | Toronto, Canada | ||
Venture capital fund focused on early-stage healthcare startups | svhealthinvestors.com | Boston, United States | ||
Healthcare ecosystem is supported through investment and innovation by Deerfield. | deerfield.com | New York, United States | ||
Real estate services are provided by Deerfield Management Group. | deerfieldmg.com | Pittsburgh, United States | ||
Executive management services are provided to affiliated instrumentation companies. | 2003 | novavg.com | Wakefield, United States | |
Platform that designs and manufactures a wide range of products and solutions in the area of consumer electronics | 1891 | philips.es | Amsterdam, Netherlands |
Investor details for SpectraWAVE
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SpectraWAVE
20 people are tracked at SpectraWAVE (16 in leadership, 4 in team); the tracked headcount is 36.
| Name | Role | Group |
|---|---|---|
Gregg Stone | Co-Founder | Leadership |
Guillermo Tearney | Co-Founder | Leadership |
James Muller | Co-Founder & CMO | Leadership |
Eman Namati | CEO | Leadership |
Amanda Gilbert | Senior Director, Human Resources | Leadership |
Maria Jesus Perez | Head Of QA | Leadership |
Brian Sundell | Senior Director Of Clinical Affairs | Leadership |
Duane Wilder | Vice President of Sales | Leadership |
Vivek Walimbe | Chief Operating Officer | Leadership |
Bill Kelly | Chief Financial Officer | Leadership |
Brad Davis | Chief Commercial Officer | Leadership |
Will Goth, PhD | Director Of Systems & Program Integration | Leadership |
Sean Pszenny | Senior Director Hardware And Operations | Leadership |
Lori-Anne Jorgensen | Sr. Director, Finance & Administration | Leadership |
Jason Tucker - Schwartz, PhD | Vice President Of Marketing And Business Development | Leadership |
Peter Strickler | Director of Manufacturing | Leadership |
Demitra Tamvaklis | Senior Staff Accountant | Team |
Kristen Leach | Senior Product Marketing Manager | Team |
Erica Sarvis | Medical Education Manager | Team |
Gabriel L. | Software Quality Assurance Engineer | Team |
Complete people profiles for SpectraWAVE
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of SpectraWAVE
4 dated milestones of SpectraWAVE across 13 years, from founding to its latest funding, stage changes and deals.
- Founded SpectraWAVE is founded.
- Funding First funding round of $16.4M.
- Funding Latest funding round, Series B, of $50.3M.
- Exit Acquired by Philips.
Competitors of SpectraWAVE
SpectraWAVE has 2 listed competitors in our database, 2 of them funded. They include NinePoint Medical and Ionpath.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ninepointmedical.com | 2008 | Bedford, United States | $98.26M | 25 | Optical coherence tomography systems for tissue microstructure imaging are developed. | |
| ionpath.com | 2014 | Menlo Park, United States | $18M | 37 | Multiplexed ion beam imaging platform for tissue biopsies is developed. |
Detailed competitors of SpectraWAVE
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SpectraWAVE
The website of SpectraWAVE (spectrawave.com) receives about 4.2K visits a month.
- Monthly visits4.2K
▲ 65.4% vs previous month
Top companies in Imaging Diagnostics
3 companies that operate in the same segment as SpectraWAVE (Imaging Diagnostics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 464 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Spectrawave
Complete news archive for SpectraWAVE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SpectraWAVE
SpectraWAVE was founded in 2012 and raised its 1st funding round 7 years after it was founded.
SpectraWAVE is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Eman Namati is the CEO of SpectraWAVE, as recorded in our data.
SpectraWAVE is a funded company, having raised a total of $79.88M across 3 funding rounds to date. The company's 1st funding round was a Series A of $16.4M, raised on May 2019.
SpectraWAVE has 36 employees.
SpectraWAVE was founded in 2012 and is headquartered in Waltham, United States. Optical diagnostic and therapeutic devices are developed for the diagnosis and treatment of cardiovascular disease within the medical devices sector. Photonic imaging technology is employed to enable precise cardiovascular assessments. Operations center on advancing non-invasive solutions for clinical applications in cardiology.
SpectraWAVE's top competitors include Ionpath and NinePoint Medical.
SpectraWAVE offers HyperVue Imaging System and Starlight Imaging Catheter.
SpectraWAVE has 9 investors. Key investors include Nova Ventures Group, Philips, Johnson & Johnson Innovation – JJDC, S3 Ventures, and Lumira Ventures.
SpectraWAVE operates through Spectrawave, Inc..
Yes. SpectraWAVE was acquired by Philips in December 2025.